Skip to main content

What the FDA labels say about taking them together

Linagliptin and rifampin

Linagliptin's FDA label of March 21, 2025 names rifampin in its drug interactions section; the rifampin label PlainMeds reads does not name linagliptin. The linagliptin label: “DRUG INTERACTIONS Strong P-glycoprotein/CYP3A4 inducer: The efficacy of TRADJENTA may be reduced when administered in combination (e.g., with rifampin).”

Check it at the source: the linagliptin FDA label on DailyMed (effective March 21, 2025, Boehringer Ingelheim Pharmaceuticals, Inc.); the rifampin FDA label on DailyMed (effective February 11, 2026, Lupin Pharmaceuticals, Inc.).

What does the linagliptin label say about rifampin?

Linagliptin label, drug interactions

DRUG INTERACTIONS Strong P-glycoprotein/CYP3A4 inducer: The efficacy of TRADJENTA may be reduced when administered in combination (e.g., with rifampin).

Source: FDA drug label (Tradjenta), Boehringer Ingelheim Pharmaceuticals, Inc., effective March 21, 2025 (SPL set c797ea5c-cab7-494b-9044-27eba0cfe40f), via openFDA; the full label on DailyMed

What does the rifampin label say about linagliptin?

Rifampin's label (effective February 11, 2026) does not name linagliptin in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (rifampin), Lupin Pharmaceuticals, Inc., effective February 11, 2026 (SPL set b56004f0-f23d-47f6-80c7-39884fccbccc), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

0Linagliptin generic labelers
13Rifampin generic labelers
LinagliptinRifampin
Labeled forType 2 diabetesn/a
Boxed warningNoNo
Pharmacy cost (NADAC)$16.80 per tablet 5 mg tablet$0.679 per capsule 300 mg capsule
Shortage nowNo current entryIn shortage

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?